Fund details
Series |
Currency |
Fund code |
MER * (%) |
---|---|---|---|
F | CAD | 35103 | 0.27% |
To provide long-term capital growth, while minimizing the exposure to currency fluctuations between foreign currencies and the Canadian dollar. The fund invests primarily in equity securities to track the performance of the benchmark, indirectly by investing in units of the iShares Core MSCI EAFE IMI Index ETF. The fund will use derivatives, such as options, futures and forward contracts to hedge against the currency fluctuations between foreign currencies and the Canadian dollar.
Series |
Currency |
Fund code |
MER * (%) |
---|---|---|---|
F | CAD | 35103 | 0.27% |
Top 10 Holdings |
% Assets |
---|---|
CAD CASH | 2.0% |
iShares Core MSCI EAFE ETF | 1.5% |
SAP SE | 1.4% |
Nestle SA | 1.3% |
ASML Holding NV | 1.3% |
Roche Holding AG | 1.1% |
AstraZeneca PLC | 1.1% |
Shell PLC | 1.1% |
Novo Nordisk A/S - Class B Shares | 1.1% |
Novartis AG | 1.1% |
Total % of Top 10 Holdings | 13.0% |
1 Mth | 3 Mth | 6 Mth | 1 year | 3 years | 5 years | 10 years | Since Inception | |||
---|---|---|---|---|---|---|---|---|---|---|
-2.3 | 3.4 | 2.6 | 5.7 | 10.3 | 14.7 | - | 9.6 | Fund |
YTD* | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Total distributions | 0.00 | 0.18 | 0.62 | 0.35 | 0.26 | 0.25 | 0.72 | 0.35 | 1.50 | 0.14 | --- |
Interest | --- | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 1.47 | 0.14 | --- |
Canadian dividends | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
Foreign dividends | --- | 0.17 | 0.62 | 0.34 | 0.25 | 0.24 | 0.53 | 0.35 | 0.03 | --- | --- |
Foreign taxes paid | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
Capital gains | --- | --- | --- | --- | --- | --- | 0.19 | --- | --- | --- | --- |
Return of capital | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
* MER (%) is based on actual expenses for the preceding calendar year or most recent half-year period ended June 30 expressed on an annualized basis, depending on availability of date at the time of publication.